Firebrick Pharma Opens Share Purchase Plan; Shares Fall 4%

MT Newswires Live09-17

Firebrick Pharma (ASX:FRE) opened a share purchase plan on Tuesday to raise up to AU$2 million, according to a same-day filing with the Australian bourse.

As previously disclosed, shareholders on record as of Sept. 11 will be able to buy up to AU$30,000 worth of ordinary shares at AU$0.055 apiece.

Proceeds from the capital raise will be used for general working capital and to expand marketing activities for the Nasodine nasal spray in the US and Singapore, the pharmaceutical firm said in the filing.

The share purchase plan is set to close on Oct. 7, with the issue and quotation of shares on the Australian bourse scheduled for Oct. 10.

Shares of Firebrick Pharma fell nearly 4% in recent Tuesday trade.

Price (AUD): $0.05, Change: $-0.0020, Percent Change: -3.57%

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2468386405?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-09-17 13:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2468386405","market":"sg","top_or_hot":-1,"title":"Firebrick Pharma Opens Share Purchase Plan; Shares Fall 4%","media":"MT Newswires Live","content":"<html><body><p> Firebrick Pharma (ASX:FRE) opened a share purchase plan on Tuesday to raise up to AU$2 million, according to a same-day filing with the Australian bourse.</p><p>As previously disclosed, shareholders on record as of Sept. 11 will be able to buy up to AU$30,000 worth of ordinary shares at AU$0.055 apiece.</p><p>Proceeds from the capital raise will be used for general working capital and to expand marketing activities for the Nasodine nasal spray in the US and Singapore, the pharmaceutical firm said in the filing.</p><p>The share purchase plan is set to close on Oct. 7, with the issue and quotation of shares on the Australian bourse scheduled for Oct. 10.</p><p>Shares of Firebrick Pharma fell nearly 4% in recent Tuesday trade.</p><p>Price (AUD): $0.05, Change: $-0.0020, Percent Change: -3.57%</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Firebrick Pharma Opens Share Purchase Plan; Shares Fall 4%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFirebrick Pharma Opens Share Purchase Plan; Shares Fall 4%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-09-17 13:45 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Firebrick Pharma (ASX:FRE) opened a share purchase plan on Tuesday to raise up to AU$2 million, according to a same-day filing with the Australian bourse.As previously disclosed, shareholders on ...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"XAO.AU","symbol_name":"标普/澳交所 普通股指数","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2468386405","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2468386405","pubTimestamp":1726551927,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Firebrick Pharma  opened a share purchase plan on Tuesday to raise up to AU$2 million, according to a same-day filing with the Australian bourse.As previously disclosed, shareholders on record as of Sept. 11 will be able to buy up to AU$30,000 worth of ordinary shares at AU$0.055 apiece.Proceeds from the capital raise will be used for general working capital and to expand marketing activities for the Nasodine nasal spray in the US and Singapore, the pharmaceutical firm said in the filing.The share purchase plan is set to close on Oct. 7, with the issue and quotation of shares on the Australian bourse scheduled for Oct. 10.Shares of Firebrick Pharma fell nearly 4% in recent Tuesday trade.Price : $0.05, Change: $-0.0020, Percent Change: -3.57%","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"XAO.AU":"标普/澳交所 普通股指数","BK4125":"广播","XJO.AU":"标普/澳交所 200指数","AUD":"Audacy Inc.","XKO.AU":"标普/澳交所 300指数","FRE.AU":"FIREBRICK PHARMA LTD","BK7096":"制药"},"translate_title":"Firebrick Pharma启动股票购买计划；股价下跌4%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AUD":1,"FRE.AU":0.9,"XAO.AU":0.76,"XJO.AU":0.76,"XKO.AU":0.76},"content_text":"Firebrick Pharma (ASX:FRE) opened a share purchase plan on Tuesday to raise up to AU$2 million, according to a same-day filing with the Australian bourse.As previously disclosed, shareholders on record as of Sept. 11 will be able to buy up to AU$30,000 worth of ordinary shares at AU$0.055 apiece.Proceeds from the capital raise will be used for general working capital and to expand marketing activities for the Nasodine nasal spray in the US and Singapore, the pharmaceutical firm said in the filing.The share purchase plan is set to close on Oct. 7, with the issue and quotation of shares on the Australian bourse scheduled for Oct. 10.Shares of Firebrick Pharma fell nearly 4% in recent Tuesday trade.Price (AUD): $0.05, Change: $-0.0020, Percent Change: -3.57%","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2468386405"}